| The updated landscape of tumor microenvironment and drug repurposing MZ Jin, WL Jin Signal transduction and targeted therapy 5 (1), 166, 2020 | 963 | 2020 |
| Reprogramming of the tumor in the hypoxic niche: the emerging concept and associated therapeutic strategies GZ Qiu, MZ Jin, JX Dai, W Sun, JH Feng, WL Jin Trends in pharmacological sciences 38 (8), 669-686, 2017 | 213 | 2017 |
| Microglia in neurodegenerative diseases Y Xu, MZ Jin, ZY Yang, WL Jin Neural Regeneration Research 16 (2), 270-280, 2021 | 122 | 2021 |
| Immunogenic cell death-based cancer vaccines MZ Jin, XP Wang Frontiers in immunology 12, 697964, 2021 | 83 | 2021 |
| Organoids: An intermediate modeling platform in precision oncology MZ Jin, RR Han, GZ Qiu, XC Ju, G Lou, WL Jin Cancer letters 414, 174-180, 2018 | 83 | 2018 |
| Long non-coding RNA DANCR as an emerging therapeutic target in human cancers SJ Jin, MZ Jin, BR Xia, WL Jin Frontiers in oncology 9, 1225, 2019 | 70 | 2019 |
| Live or let die: Neuroprotective and anti-cancer effects of nutraceutical antioxidants XY Mao, MZ Jin, JF Chen, HH Zhou, WL Jin Pharmacology & Therapeutics 183, 137-151, 2018 | 65 | 2018 |
| Organoid of ovarian cancer: genomic analysis and drug screening HD Liu, BR Xia, MZ Jin, G Lou Clinical and Translational Oncology 22, 1240-1251, 2020 | 58 | 2020 |
| Organoid models of glioblastoma: advances, applications and challenges C Zhang, M Jin, J Zhao, J Chen, W Jin American Journal of Cancer Research 10 (8), 2242, 2020 | 45 | 2020 |
| The bad seed gardener: deubiquitinases in the cancer stem-cell signaling network and therapeutic resistance GZ Qiu, W Sun, MZ Jin, J Lin, PG Lu, WL Jin Pharmacology & therapeutics 172, 127-138, 2017 | 39 | 2017 |
| Ubiquitin‐specific protease 22 acts as an oncoprotein to maintain glioma malignancy through deubiquitinating B cell‐specific Moloney murine leukemia virus integration site 1 … GZ Qiu, XY Mao, Y Ma, XC Gao, Z Wang, MZ Jin, W Sun, YX Zou, J Lin, ... Cancer Science 109 (7), 2199-2210, 2018 | 36 | 2018 |
| Curaxin CBL0137 exerts anticancer activity via diverse mechanisms MZ Jin, BR Xia, Y Xu, WL Jin Frontiers in oncology 8, 598, 2018 | 34 | 2018 |
| Exosomes: powerful weapon for cancer nano-immunoengineering YN Pi, BR Xia, MZ Jin, WL Jin, G Lou Biochemical pharmacology 186, 114487, 2021 | 31 | 2021 |
| Critical involvement of lysyl oxidase in seizure-induced neuronal damage through ERK-Alox5-dependent ferroptosis and its therapeutic implications X Mao, X Wang, M Jin, Q Li, J Jia, M Li, H Zhou, Z Liu, W Jin, Y Zhao, ... Acta Pharmaceutica Sinica B 12 (9), 3513-3528, 2022 | 24 | 2022 |
| A pan-cancer analysis of the oncogenic and immunogenic role of m6Am methyltransferase PCIF1 MZ Jin, YG Zhang, WL Jin, XP Wang Frontiers in Oncology 11, 753393, 2021 | 16 | 2021 |
| Organoids: a platform ready for glioblastoma precision medicine? WL Jin, MZ Jin, YY Tu Trends in cancer 6 (4), 265-267, 2020 | 11 | 2020 |
| Reclassification of hepatocellular cancer with neural-related genes YG Zhang, MZ Jin, XR Zhu, WL Jin Frontiers in Oncology 12, 877657, 2022 | 8 | 2022 |
| Single-cell map of diverse immune phenotypes in the metastatic brain tumor microenvironment of non small cell lung cancer L Wang, J Dai, RR Han, L Dong, D Feng, G Zhu, W Guo, Y Wang, M Chao, ... bioRxiv, 2019.12. 30.890517, 2019 | 8 | 2019 |
| Single-cell map of diverse immune phenotypes in the metastatic brain tumor microenvironment of nonsmall-cell lung cancer L Wang, M Chao, RR Han, L Li, L Dong, F Chen, MZ Jin, L Gao, Y Wang, ... International Journal of Surgery 111 (1), 1601-1606, 2025 | 1 | 2025 |
| Spatial epigenome–transcriptome comapping technology MZ Jin, WL Jin Trends in Cell Biology 33 (6), 449-450, 2023 | 1 | 2023 |
Wei-Lin JinAssociate Investigator of Neurobiology, Shanghai Jiao Tong UniversityDirección de correo verificada de sjtu.edu.cn
